EP News: Clinical
van Rein et al (Circulation 2019;139:775, PMID 30586754) evaluated bleeding rates in a comprehensive national database of patients with atrial fibrillation (AF) who were 50 years and older. Treatments included vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs), platelet inhibitors, and combinati ons of antithrombotic drugs. Major bleeding was defined as bleeding requiring hospitalization or causing death. Overall, 272,315 patients with AF were followed for 1,373,131 patient-years (PYs); 31,459 major bleeds occurred for an incidence rate (IR) of 2.3 per 100 PYs.
Source: Heart Rhythm - Category: Cardiology Authors: N.A. Mark Estes Tags: EP News Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Databases & Libraries | Heart | Vitamin K | Vitamins